Data Management And Sharing System of China National Clinical Research Center for Neurological Diseases
Validation of the Essen Stroke Risk Score and the Stroke Prognosis Instrument II in Chinese Patients
First author：Xia Meng,Yilong Wang
Corresponding author：Yongjun Wang
essential_information
- Person in charge：Xia Meng,Yilong Wang
- Data Sources： CNSR-I
- Number of papers：CNSR-I20180066
- Published time：2011-12-01
2011-12-01
Published articles
Journal：Stroke
Publication type: Original Contributions
IF(IF): 7.914
PMID: 22020029 Link To Pubmed Full text Download
Background And Purpose
Little was known about the predictive accuracy of the Essen Stroke Risk Score and the Stroke Prognostic Instrument II in Chinese patients with stroke.
Method
We evaluated the predictive accuracy of both Essen Stroke Risk Score and Stroke Prognostic Instrument II scores for both recurrent stroke and combined vascular events using data from a prospective cohort of 11 384 patients with acute ischemic stroke and transient ischemic attack admitted to 132 urban hospitals throughout China.
Conclusion
In Chinese patients with ischemic stroke or transient ischemic attack, both Essen Stroke Risk Score and Stroke Prognostic Instrument II scores are equally able to stratify the risk of recurrent stroke and combined vascular events.
Main results
The cumulative 1-year event rates were 16% (95% CI, 15%–16%) for recurrent stroke and 18% (95% CI, 18%–19%) for combined vascular events. Both event rates were significantly higher in patients with transient ischemic attack and increased significantly from lower to higher Essen Stroke Risk Score and Stroke Prognostic Instrument II categories. Essen Stroke Risk Score and Stroke Prognostic Instrument II had similar predictive accuracies for each study outcome.